Description:

North Central Cancer Treatment Group N0577 Arm B & C Evaluation/Treatment Form NCT00887146 Radiation Therapy or Radiation Therapy and Temozolomide or Temozolomide Alone in Treating Patients With Newly Diagnosed Anaplastic Glioma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=4C094A66-1244-40DD-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=4C094A66-1244-40DD-E044-0003BA3F9857

Keywords:
Versions (3) ▾
  1. 8/26/12
  2. 1/8/15
  3. 6/8/15
Uploaded on:

June 8, 2015

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

North Central Cancer Treatment Group N0577 Arm B & C Evaluation/Treatment Form NCT00887146

No Instruction available.

  1. StudyEvent: North Central Cancer Treatment Group N0577 Arm B & C Evaluation/Treatment Form
    1. No Instruction available.
Header
Are data amended (If yes, highlight amended areas)
Assessment of Chemotherapy
Kg
ECOG Performance Status (check one used for this cycle)
Was this cycle of treatment held (check one)
Primary reason treatment held (If yes, planned or unplanned)
Were there any dose modifications or additions/omissions to protocol treatment? (Days 1-21 mg)
Reason(s) Modified (If Yes, per Section 8.0. Not BSA changes)